Dr.M. Necmettin ATSÜ'nün Basılı Kitap ve Yayınları
A 1. ?ge ?, Erdem E, Atsü N, Şahin A, Özen H. Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor. Eur Urol. 2000 March; 37: 271-4
A 2. Tekin A, Tekgul S, Atsü N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol. 2000 Jul;164(1):162-5
A 3. ?ge ?, Atsü N, Şahin A, özen H. Comparison of BTA stat and NMP22 tests in the detection of bladder cancer. Scand J Urol Nephrol. 2000 Dec; 34: 349-51
A 4. Tekin A, Tekgul S, Atsü N, Ergen A, Kendi S. Ureteropelvic junction obstruction and coexisting renal calculi in children: role of metabolic abnormalities. Urology. 2001 Mar;57(3):542-5; discussion 545-6 ...[Devamı...]
A 5. Akdağ D, Özen H, Atsü N, Tekin A, Sözen S, Tun?bilek E. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker for invasive bladder cancer? Cancer Gen Cytogen. 2001 Feb; 125: 1-4 (Lead article)
A 6. Tekin A, Tekgul S, Atsü N, Sahin A, Bakkaloglu M. Cyst?ne calculi in children: the results of a metabolic evaluation and response to medical therapy. J Urol. 2001 Jun;165(6 Part 2):2328-2330
A 7. Şahin A, Atsü N, Erdem E, üner S, Bilen C, Bakkalo?lu M, Kendi S. Percutaneous Nephrolithotomy in Patients Aged 60 Years or Older. J. Endourol. 2001 June; 15(5): 489-9
A 8. ?ge ?, Şahin A, Atsü N, Kendi S. Trans-uretero-ureterostomy with a blind-ending ureteral duplication. Geriatric Nephrology and Urology. 2001; 32: 343-4
A 9. ?ge ?, Atsü N, Şahin A, , Kendi S. Özen H. Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer. Geriatric Nephrology and Urology. 2001; 32: 367-70
A 10. Toruner GA, Akyerli C, Ucar A, Aki T, Atsu N, Ozen H, Tez M, Cetinkaya M, Ozcelik T Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol. 2001 Oct;75(8):459-64.
A 11. Ats? N, Ekici S, ?ge ?, Ergen A, Hasçelik G, Özen H. False Positive Results of The NMP22? Tests Due to Hematuria. J Urol. 2002 Feb;167(2 Pt 1):555-8.
A 12. Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. J Urol. 2002 Dec;168(6):2572-4.
A 13. Tekin A, Atsu N, Ozen H. Daily variability of serum prostate-specific antigen in men over 50 years of age. Int Urol Nephrol. 2001;33(4):641-4.
A 14. Erdem E, Dikmen G, Atsu N, Dogan P, Ozen H. Telomerase activity in diagnosis of bladder cancer. Scand J Urol Nephrol. 2003;37(3):205-9.
A 15. Atsu N, Eskicorapci S, Uner A, Ekici S, Gungen Y, Erkan I, Uygur MC, Ozen H. A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours. BJU Int. 2003 Jul;92(1):32-5.
A 16. Erdem E, Atsu N, Akbal C, Bilen CY, Ergen A, Ozen H. The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer. Int Urol Nephrol. 2002-2003;34(4):519-23
A 17. Eskicorapcı S. Ekici S., Atsu M N, Dogan R, Ozen H. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors. Int J Urol. 2004; 11:634-9